INS and Obesity: Our data revealed that 11 weeks of a high-carbohydrate diet, or the administration of a single intraperitoneal injection of streptozotocin, resulted in a modest model of obesity or diabetes, as demonstrated by changes in body weight, blood glucose levels, plasma insulin, and plasma leptin levels.